NeuroAiD™, the treatment for stroke patients

NeuroAiD™ (MLC 601) is a natural medicine indicated for post stroke rehabilitation. NeuroAiD™ offers a new solution to support stroke sufferers achieve better neurological and functional recovery.

During stroke recovery you will be learning over and regaining skills to be as independent as possible. Since your potential to recover will diminish over time, the earlier the right rehabilitation program is initiated, the more chances you have to recover lost functions.

If you start taking NeuroAiD™

• Less than six months after the stroke onset:

In this favorable time window for recovery most patients achieve visible progress on a monthly basis. Clinical trials performed in 605 patients established that patients taking NeuroAiD™ achieved a significantly better recovery.

Recovering independence: Patients taking NeuroAiD™ more than double their chances to recover independence (x2.4 times) compared to patients not taking NeuroAiD™.

Reducing disabilities: Patients treated with NeuroAiD™ recover on average 25% more their motor deficits than patients not treated with NeuroAiD™.

To ensure best efficacy, NeuroAiD™ should be taken together with intense physical therapy.

• Six months after the stroke onset and beyond:

By this time, many may feel left to cope with a very slow progress, if any at all. Yet experience has shown that adding NeuroAiD™ to the patients’ rehabilitation program can still provide significant improvements and relief.

Many patients tried NeuroAiD™ more than six months after their stroke and reported reduced spasticity and significant improvements in their motor, speech, walk, and vision abilities after completing the treatment.

• Stroke prevention and other neurological diseases:

NeuroAiD™ has not been studied clinically on other indications. However, both in vitro and animal testing indicated a prolongation of the lifespan of neurons against natural aging and further protections against external event aggressions. It has also shown that the surviving neurons are stronger and healthier.

As such and given its excellent safety profile, we are planning more studies on NeuroAiD™ to evaluate its potential role on slowing down cognitive decline, including Alzheimer Disease, and other neurodegenerative diseases and possibly as an add-on to stroke prevention treatment. This research will be conducted in 2011-12 onwards.

To receive a personal advice on our Stroke treatment, please fill up our form and a product specialist will get back to you.

If you want to know how other patients rated their experience with the NeuroAiD treatment, read our NauroAiD patient survey report by clicking here.

Email Print PDF